New year. New momentum. New science. InnoPharm Session Highlight
One of the most anticipated sessions at InnoPharm focuses on 𝐀𝐈-𝐃𝐫𝐢𝐯𝐞𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 & 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 Why this session is being highlighted: Artificial Intelligence is no longer experimental in pharma - it’s actively transforming how molecules are identified, optimized, and advanced into the clinic. This session explores how AI and machine learning are accelerating timelines, reducing R&D costs, and strengthening decision-making across drug discovery pipelines. From target identification to predictive toxicology, the discussion reflects where the industry is heading and why AI has become a strategic priority for pharma and biotech leaders in 2026 and beyond.
